tranylcypromine [Ligand Id: 5281] activity data from GtoPdb and ChEMBL
Click here for a description of the charts and data table
Please tell us if you are using this feature and what you think!
| ChEMBL ligand: CHEMBL313833 |
|---|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
| DB | Assay description | Assay Type | Standard value | Standard parameter | Original value | Original units | Original parameter | Reference |
|---|---|---|---|---|---|---|---|---|
| CYP2B6/Cytochrome P450 2B6 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4729] [GtoPdb: 1324] [UniProtKB: P20813] | ||||||||
| ChEMBL | Fluorescent High Throughput P450 Assay: The interaction of SC12 with cytochrome P450 enzymes was tested using Fluorescent High Throughput P450 assays (Gentest); The IC50s of the compounds was calculated on isoenzymes (CYP1A2, CYP2C9, CYP2C19, CYP2C8, CYP2B6, CYP2D6, CYP2E1, CYP3A4 and CYP3A5). Inhibition of the P450 isoforms was measured in specific assays using specific substrates that become fluorescent upon CYP metabolism. Compounds, dissolved in ACN (acetonitrile) (CYP2E1, CYP2C8, CYP2B6, CYP3A5) or DMSO (all remaining isoforms), were tested in duplicate (n=2) in concentration-response curves (eight concentrations) in a 96-well plate containing incubation/NADPH regenerating buffer. Specific isoenzymes and substrates were added and incubated at 37° C. Reactions were terminated at different times, depending on the assays, and plates read on a Fluoroskan Ascent at the appropriate emission/excitation wavelengths. Concentration-response curves performed in duplicate for known inhibitors for each isoenzyme were tested in ever | B | 5.16 | pIC50 | 6900 | nM | IC50 | US-9173935-B2. Phospholipid drug analogs (2015) |
| CYP2C19/Cytochrome P450 2C19 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3622] [GtoPdb: 1328] [UniProtKB: P33261] | ||||||||
| ChEMBL | Fluorescent High Throughput P450 Assay: The interaction of SC12 with cytochrome P450 enzymes was tested using Fluorescent High Throughput P450 assays (Gentest); The IC50s of the compounds was calculated on isoenzymes (CYP1A2, CYP2C9, CYP2C19, CYP2C8, CYP2B6, CYP2D6, CYP2E1, CYP3A4 and CYP3A5). Inhibition of the P450 isoforms was measured in specific assays using specific substrates that become fluorescent upon CYP metabolism. Compounds, dissolved in ACN (acetonitrile) (CYP2E1, CYP2C8, CYP2B6, CYP3A5) or DMSO (all remaining isoforms), were tested in duplicate (n=2) in concentration-response curves (eight concentrations) in a 96-well plate containing incubation/NADPH regenerating buffer. Specific isoenzymes and substrates were added and incubated at 37° C. Reactions were terminated at different times, depending on the assays, and plates read on a Fluoroskan Ascent at the appropriate emission/excitation wavelengths. Concentration-response curves performed in duplicate for known inhibitors for each isoenzyme were tested in ever | B | 5.3 | pIC50 | 5000 | nM | IC50 | US-9173935-B2. Phospholipid drug analogs (2015) |
| lysine demethylase 1A/Lysine-specific histone demethylase 1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL6136] [GtoPdb: 2669] [UniProtKB: O60341] | ||||||||
| GtoPdb | In vitro KDM1A demethylation assay using purified human KDM1A protein and dimethylated H3K4 peptide as substrate. | - | 4.4 | pIC50 | 39660 | nM | IC50 | MBio (2013) 4: e00558-12 [PMID:23386436] |
| ChEMBL | Inhibition of recombinant LSD1 (157 to 852 amino acids) (unknown origin) expressed in Escherichia coli BL21(DE) using H3K4me2 substrate by amplex red and horseradish peroxidase based fluorescence assay | B | 4.53 | pIC50 | 29310 | nM | IC50 | Eur J Med Chem (2017) 140: 392-402 [PMID:28987602] |
| ChEMBL | Inhibition of human recombinant N-terminal His/GST-tagged LSD1 (172 to 852 residues) expressed in baculovirus infected insect cells using biotin-labeled H3K4me2 (1 to 24 residues) as substrate after 1 hr by TR-FRET assay | B | 4.65 | pIC50 | 22300 | nM | IC50 | Eur J Med Chem (2017) 141: 101-112 [PMID:29031059] |
| lysine demethylase 1B/Lysine-specific histone demethylase 1B in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1938208] [GtoPdb: 2670] [UniProtKB: Q8NB78] | ||||||||
| ChEMBL | Inhibition of human full length LSD2 using biotin-labeled H3K4me2 (1 to 24 residues) as substrate after 1 hr by TR-FRET assay | B | 4 | pIC50 | >100000 | nM | IC50 | Eur J Med Chem (2017) 141: 101-112 [PMID:29031059] |
| Monoamine oxidase A in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1951] [GtoPdb: 2489] [UniProtKB: P21397] | ||||||||
| GtoPdb | - | - | 4.7 | pIC50 | 20000 | nM | IC50 | Bioorg Med Chem (2004) 12: 2645-52 [PMID:15110846] |
| ChEMBL | Inhibition of human recombinant MAO-A expressed in baculovirus infected insect cells by luminescence assay | B | 4.94 | pIC50 | 11500 | nM | IC50 | Eur J Med Chem (2017) 141: 101-112 [PMID:29031059] |
| ChEMBL | Inhibition of MAOA (unknown origin) using beetle luciferin as substrate by MAO-Glo assay | B | 5.33 | pIC50 | 4720 | nM | IC50 | Eur J Med Chem (2017) 140: 392-402 [PMID:28987602] |
| Monoamine oxidase B in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2039] [GtoPdb: 2490] [UniProtKB: P27338] | ||||||||
| GtoPdb | - | - | 4.72 | pIC50 | 19000 | nM | IC50 | Bioorg Med Chem (2004) 12: 2645-52 [PMID:15110846] |
| ChEMBL | Inhibition of human recombinant MAO-B expressed in baculovirus infected insect cells by luminescence assay | B | 5.15 | pIC50 | 7000 | nM | IC50 | Eur J Med Chem (2017) 141: 101-112 [PMID:29031059] |
| ChEMBL | Inhibition of MAOB (unknown origin) using beetle luciferin as substrate by MAO-Glo assay | B | 5.53 | pIC50 | 2950 | nM | IC50 | Eur J Med Chem (2017) 140: 392-402 [PMID:28987602] |
ChEMBL data shown on this page come from version 33:
Mendez D, Gaulton A, Bento AP, Chambers J, De Veij M, Félix E, Magariños MP, Mosquera JF, Mutowo P, Nowotka M, Gordillo-Marañón M, Hunter F, Junco L, Mugumbate G, Rodriguez-Lopez M, Atkinson F, Bosc N, Radoux CJ, Segura-Cabrera A, Hersey A, Leach AR. (2019) 'ChEMBL: towards direct deposition of bioassay data' Nucleic Acids Res., 47(D1). DOI: 10.1093/nar/gky1075. [EPMCID:30398643]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]
